Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

BACKGROUND: The degree of glycemic control in patients with type 2 diabetes mellitus (T2DM) may alter lipid levels and may alter the efficacy of lipid-modifying agents. OBJECTIVE: Evaluate the lipid-modifying efficacy of extended-release niacin/laropiprant (ERN/LRPT) in subgroups of patients with T2...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold E, Brinton, Eliot A, Triscari, Joseph, Chen, Erluo, Maccubbin, Darbie, MacLean, Alexandra A, Gibson, Kendra L, Ruck, Rae Ann, Johnson-Levonas, Amy O, O’Neill, Edward A, Mitchel, Yale B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348131/
https://www.ncbi.nlm.nih.gov/pubmed/25750540
http://dx.doi.org/10.2147/VHRM.S70907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348131/
https://www.ncbi.nlm.nih.gov/pubmed/25750540
http://dx.doi.org/10.2147/VHRM.S70907

Ejemplares similares